SIG timeline
Every SIG batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| SIG-2603-6617 | Adipotide | 28 Mar 2026 | 2026-Q2 | 2 | 98.40 | 0.28 | 98.69 | +0.29 | |
| SIG-2603-6158 | Tirzepatide | 25 Mar 2026 | 2026-Q2 | 4 | 98.57 | 1.15 | 98.88 | +0.31 | |
| SIG-2603-6031 | GHRP-2 | 12 Mar 2026 | 2026-Q3 | 13 | 99.11 | 1.06 | 98.89 | -0.22 | |
| SIG-2603-6212 | Cagrilintide | 05 Mar 2026 | 2026-Q2 | 14 | 98.27 | 0.89 | 98.42 | +0.15 | |
| SIG-2602-5969 | Semax | 11 Feb 2026 | 2026-Q2 | 5 | 99.13 | 0.82 | 98.65 | -0.48 | |
| SIG-2602-6794 | PEG-MGF | 09 Feb 2026 | 2026-Q2 | 13 | 97.75 | 1.30 | 98.00 | +0.25 | |
| SIG-2602-5701 | Melanotan II | 04 Feb 2026 | 2026-Q1 | 1 | 99.12 | n<2 | 99.59 | +0.47 | |
| SIG-2512-6369 | SS-31 (Elamipretide) | 21 Dec 2025 | 2026-Q1 | 8 | 99.32 | 0.83 | 99.36 | +0.04 | |
| SIG-2512-6026 | Tirzepatide | 21 Dec 2025 | 2026-Q2 | 12 | 98.26 | 0.87 | 98.40 | +0.14 | |
| SIG-2511-5925 | Semaglutide | 27 Nov 2025 | 2026-Q1 | 9 | 98.50 | 0.80 | 98.28 | -0.22 | |
| SIG-2511-5466 | Ipamorelin | 24 Nov 2025 | 2026-Q2 | 2 | 99.36 | 0.75 | 99.77 | +0.41 | |
| SIG-2511-6924 | Retatrutide | 07 Nov 2025 | 2025-Q4 | 2 | 97.40 | 0.91 | 97.62 | +0.22 | |
| SIG-2510-6072 | Ipamorelin | 16 Oct 2025 | 2025-Q4 | 4 | 98.93 | 0.15 | 99.27 | +0.34 | |
| SIG-2508-6459 | Liraglutide | 15 Aug 2025 | 2026-Q1 | 7 | 98.48 | 1.40 | 98.74 | +0.26 | |
| SIG-2508-6037 | Retatrutide | 08 Aug 2025 | 2025-Q3 | 2 | 97.13 | 1.68 | 97.35 | +0.22 | |
| SIG-2505-6162 | Tirzepatide | 28 May 2025 | 2025-Q3 | 3 | 98.38 | 1.02 | 98.44 | +0.06 | |
| SIG-2505-6146 | Epitalon | 28 May 2025 | 2025-Q2 | 4 | 98.87 | 0.27 | 99.03 | +0.16 | |
| SIG-2505-6919 | Vilon | 22 May 2025 | 2025-Q4 | 2 | 98.28 | 0.21 | 98.01 | -0.27 | |
| SIG-2505-5831 | Selank | 15 May 2025 | 2025-Q4 | 2 | 99.23 | 0.32 | 99.71 | +0.48 | |
| SIG-2504-6873 | Semax | 09 Apr 2025 | 2025-Q3 | 2 | 98.58 | 0.41 | 98.49 | -0.09 | |
| SIG-2503-6560 | GHK-Cu | 06 Mar 2025 | 2025-Q2 | 3 | 98.28 | 0.69 | 98.44 | +0.16 | |
| SIG-2412-6325 | Epitalon | 05 Dec 2024 | 2025-Q1 | 12 | 99.10 | 1.04 | 99.40 | +0.30 | |
| SIG-2412-6332 | MOTS-c | 03 Dec 2024 | 2025-Q1 | 2 | 98.85 | 0.01 | 99.10 | +0.25 | |
| SIG-2411-6312 | Retatrutide | 13 Nov 2024 | 2025-Q1 | 2 | 97.76 | 0.86 | 97.98 | +0.22 | |
| SIG-2405-6205 | BPC-157 | 02 May 2024 | 2024-Q2 | 2 | 98.60 | 0.39 | 99.11 | +0.51 | |
| SIG-2404-6658 | Tirzepatide | 29 Apr 2024 | 2024-Q3 | 11 | 97.58 | 0.30 | 98.41 | +0.83 | |
| SIG-2404-6898 | MK-677 (Ibutamoren mesylate) | 09 Apr 2024 | 2024-Q3 | 9 | 98.83 | 0.71 | 98.43 | -0.40 | |
| SIG-2402-6052 | L-Glutathione (reduced) | 17 Feb 2024 | 2024-Q2 | 1 | 98.73 | n<2 | 99.32 | +0.59 | |
| SIG-2402-5963 | Retatrutide | 09 Feb 2024 | 2024-Q1 | 3 | 98.24 | 0.67 | 98.86 | +0.62 | |
| SIG-2308-5947 | Epitalon | 20 Aug 2023 | 2024-Q1 | 4 | 98.91 | 0.55 | 98.86 | -0.05 |